TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC)—Background

Authors :: Tim Meyer
Richard Fox
Yuk Ting Ma
Paul J. Ross
Martin James
Richard Strugess
Clive Stubbs
Lucy Wall
Anthony Watkinson
Nigel Hacking
T.R. Jeffry Evans
Peter Collins
Richard Hubner
David Cunningham
John Neil Primrose
Philip James Johnson
Daniel H. Palmer
Source :: Journal of Clinical Oncology. 34:4018-4018
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.

Full Text Access

Tools